Hoth Therapeutics Received FDA Clearance To Broaden HT-001 Clinical Trial

(RTTNews) - Hoth Therapeutics Inc. (HOTH) on Thursday said it received clearance from the U.S. FDA to incorporate various changes in protocol for ...

Related Keywords

,Nasdaq ,Hoth Therapeutics Inc ,Epidermal Growth Factor Receptor Inhibitors ,